| Anticoagulation by ancrod for haemodialysis. | |
| | |
MedLine Citation:
|
PMID: 5485178 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The defibrinating agent ancrod (Arvin) was used instead of heparin for intermittent haemodialysis. It was an effective, and apparently safe, anticoagulant and reduced the deposition of fibrin and leucocytes on the Cellophane membrane. Administration was more complicated and urea dialysance was less with ancrod than with heparin. |
| | |
Authors:
|
G H Hall; H M Holman; A D Webster |
Related Documents
:
|
21951438 - Expressing ethical principles of treatment and care in a charter: what value? 12500588 - The case for an actuary. |
Publication Detail:
|
Type: Comparative Study; Journal Article |
Journal Detail:
|
Title: British medical journal Volume: 4 ISSN: 0007-1447 ISO Abbreviation: Br Med J Publication Date: 1970 Dec |
Date Detail:
|
Created Date: 1971-01-23 Completed Date: 1971-01-23 Revised Date: 2010-10-26 |
Medline Journal Info:
|
Nlm Unique ID: 0372673 Medline TA: Br Med J Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 591-3 Citation Subset: AIM; IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Anticoagulants / therapeutic use* Cellophane Chronic Disease Fibrin Fibrinogen / blood Heparin / therapeutic use Humans Leukocytes Male Membranes, Artificial Middle Aged Nephritis / therapy Polycystic Kidney Diseases / therapy Renal Dialysis* Urea Venoms / therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Anticoagulants; 0/Membranes, Artificial; 0/Venoms; 57-13-6/Urea; 9001-31-4/Fibrin; 9001-32-5/Fibrinogen; 9005-49-6/Heparin; 9005-81-6/Cellophane |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Urinary tract dilatation and oral contraceptives.
Next Document: Fibrosing alveolitis associated with renal tubular acidosis.